73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

by Arthur AllenCredit: CC0 Public DomainOn Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredd

Drugmakers are abandoning cheap generics, and now US cancer patients can't get meds, say doctors

by Arthur AllenCredit: CC0 Public DomainOn Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags full of shredd
Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise

Combination therapy outperforms chemotherapy in clinical trial for patients with chronic lymphocytic leukemia

by University of AmsterdamCredit: Unsplash/CC0 Public DomainChemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The dise
Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283

Everolimus inhibits angiogenesis and lymphangiogenesis in TP53 mutant HNSCC via STAT3/HIF-1α/VEGF pathway

by Impact Journals LLCEverolimus reduces microvessel density (MVD) and lymphatic vessel density (LVD) in TP53 mutant HNSCC xenografts. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.283
Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h

Early-stage cancer diagnoses decreased sharply in the US during first year of COVID-19 pandemic

by American Cancer SocietyCOVID-19 and Cancer. Credit: American Cancer SocietyA new study from researchers at the American Cancer Society (ACS) found monthly adult cancer diagnoses decreased by h
Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for

Evidence supports three-year interval for multi-target stool DNA screening for those at average risk of colon cancer

by Regenstrief InstituteCredit: Unsplash/CC0 Public DomainA scientific study exploring the appropriate interval for colorectal cancer screening via non-invasive multi-target stool DNA testing for
A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and

A brief cognitive behavioral therapy appears promising for head and neck cancer survivors

by Medical University of South CarolinaA microvascular reconstructive surgeon by training, Dr. Evan Graboyes became interested in alleviating body-image distress when he saw how much his head and
Some young cancer survivors face higher risk of premature heart failure

Some young cancer survivors face higher risk of premature heart failure

by Northwestern UniversityIncident Heart Failure Among YA Cancer Survivors (A) Comparison of history of anthracycline treatment vs none. (B) Stratified by young adult (YA) cancers commonly treate

Some young cancer survivors face higher risk of premature heart failure

by Northwestern UniversityIncident Heart Failure Among YA Cancer Survivors (A) Comparison of history of anthracycline treatment vs none. (B) Stratified by young adult (YA) cancers commonly treate
Proton radiotherapy treats esophageal cancer for first time in Switzerland

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre

Proton radiotherapy treats esophageal cancer for first time in Switzerland

by Paul Scherrer InstituteGantry 3 at the Center for Proton Therapy at PSI. With the help of this rotating treatment apparatus, cancer patients are irradiated with protons to destroy tumours. Cre
Study: Involving hospitalists in inpatient cancer care reduces patient stays, oncologist stress

Study: Involving hospitalists in inpatient cancer care reduces patient stays, oncologist stress

by Yale UniversityCredit: CC0 Public DomainInvolving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increase

Study: Involving hospitalists in inpatient cancer care reduces patient stays, oncologist stress

by Yale UniversityCredit: CC0 Public DomainInvolving hospitalists in the co-management of care for patients with cancer is associated with decreased length of hospital stay for patients, increase
Researchers develop tool to measure patient health and well-being after radionuclide therapy

Researchers develop tool to measure patient health and well-being after radionuclide therapy

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.264946Cancer is a devasting disease that

Researchers develop tool to measure patient health and well-being after radionuclide therapy

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Journal of Nuclear Medicine(2023). DOI: 10.2967/jnumed.122.264946Cancer is a devasting disease that
Investigational deep learning model may help stratify risk for patients with endometrial cancer

Investigational deep learning model may help stratify risk for patients with endometrial cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAn investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant rec

Investigational deep learning model may help stratify risk for patients with endometrial cancer

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainAn investigational deep learning model requiring one histopathologic slide accurately predicted the risk of distant rec
First-line regimens with endocrine therapy show benefits in breast cancer

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi